HK Stock Market Move | MEDBOT-B(02252) fell more than 4% in the afternoon. JP Morgan said that current valuations are relatively high and the development of automated surgery still requires time.

MEDBOT-B(02252) fell by more than 4% in the afternoon, dropping 3.79% to 21.6 Hong Kong dollars, with a turnover of 2.59 billion Hong Kong dollars as of the time of writing. JP Morgan released a research report stating that Siasun Robot&Automation has significantly outperformed the Hang Seng Index by 100% in the past two months, mainly due to the AI and robotics stock boom, as well as progress in reducing losses, with a goal of achieving breakeven next year. The company's recent profit forecast and order trends have boosted confidence in its expansion of production facilities, especially overseas. The bank points out that considering the company's sales volume, valuation is relatively higher compared to Intuitive Surgical's initial stage, so they believe there is limited upside potential in the current stock price level unless there is significant policy support. JP Morgan noted in the report that discussions at a specialist conference last week included the latest developments in AI technology in the field of robotic surgery, such as Siasun Robot&Automation, emphasizing that the development of robotic surgery takes time and must still overcome technical, ethical, and regulatory challenges. At present, AI is mainly used to assist surgical operations, such as precise navigation, intraoperative image processing, and Siasun Robot&Automation auxiliary technology, applications that have already improved surgical efficiency and patient safety, but still require oversight and involvement of surgeons.